AMED is expected to report earnings to rise 7.20% to $1.34 per share on July 23
Q2'25
Est.
$1.34
Q1'25
Beat
by $0.14
Q4'24
Missed
by $0.10
Q3'24
Missed
by $0.17
Q2'24
Beat
by $0.14
The last earnings report on April 23 showed earnings per share of $1.25, beating the estimate of $1.11. With 64.84K shares outstanding, the current market capitalization sits at 3.02B.